Clinical Trial Update: Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study [Phase 2]

View source ↗

Summary

This update reports the results of the Phase 2 SUBQ-HF trial evaluating subcutaneous furosemide for acute decompensated heart failure; the study was terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: Adrian Hernandez | Conditions: Acute Heart Failure, Decompensated Heart Failure | Phase 2 | Status: TERMINATED | Results posted: 2019-01-23